Bempedoic Acid: A New option for Statin-Intolerant Patients
Exploring Bempedoic Acid's Role in Preventing Cardiovascular Events
Topline:
A recent subgroup analysis from the CLEAR Outcomes trial highlights bempedoic acid's significant potential in reducing major adverse cardiovascular events (MACE) among high-risk, statin-intolerant patients. This finding marks a pivotal moment for patients and healthcare providers, promising a new, effective treatment path for those previously l…
